Jul 072015


Greetings!! EduCater takes pleasure in bringing Pharsight Training Programs to India to benefit the Indian Pharma Community.

We are glad to announce our 8th Phoenix WinNonlin workshop in MUMBAI, INDIA  as under:

Workshop: Introduction to Phoenix WinNonlin (PHXWNL-8) 6th -8th August, 2015 (2.5 Days Workshop)


Workshop Trainer:


Ms. Venkateswari Muthukrishnan, PhD. Senior Scientific Consultant – Pharsight Products, South Asia Pacific Certara, Implementing Translational Science

Who will benefit:

Pharmaceutical Scientists working in the areas of

Formulation Development Pharmacodynamics

Bioequivalence Clinical Pharmacology

QA/QC Pharmacology

Pharmacokinetics Toxicology

Clinical/Medical Affairs Regulatory

Biostatistics Bioanalysis


Hurry up and register today as there are limited seats only.

Kindly see the attached brochure for more information and workshop details.

Please forward this to other scientists that may be interested in this workshop.

Please feel free to contact me for registration and more information.


Dhanashri Kolwankar-Gudi

Dr. Dhanashri Gudi – Proprietor, EduCater

M: 91-9930953549




Anand Gupta

Mr. Anand Gupta – Regional Manager South Asia Pacific, Certara (Pharsight & Tripos)





Thanks and Best Regards,

Dr. Dhanashri Gudi


Educater Logo

EduCater Building Knowledge – Inspiring Minds 406-408, Swastik Chambers, Sion Trombay Rd, Chembur Mumbai 400071, India Tel: + 91-22-25278801 / 2 / 3

Fax: + 91-22-67974547 Mobile: + 91-9930953549




EduCater is one of its kinds training management company, initiated to cater to the training needs of Pharmaceutical sector in areas where formal training is lacking. EduCater in involved in conducting workshops, seminars, courses and hands-on trainings in various disciplines of applied sciences focusing on Pharmaceutical Sciences.

Our research team focuses and designs topics to benefit our clients enabling their research scientist to learn, understand and apply the knowledge/ tools and techniques in their respective areas of focus (operation).

We aim to bring the pharmaceutical industry closer together. Our motto is to build knowledge and inspire minds. Our goal through training in not to train scientist to make them good technicians but to educate and inspire them to make them leaders and help their professional growth.

We conduct training programs where in the speakers are world renowned in their respective fields. We limit the courses to a smaller numbers of participants to enable them the opportunity for thorough discussion of the issues to be covered by the training program and one-to-one consultation with speaker(s).







Certara: Translational Science Solutions

Biosimulation Software and Consulting for Drug Development



Certara, the leading biosimulation company, provides technology-enabled solutions to the global biopharmaceutical industry. We have brought together the leaders in biosimulation and regulatory writing—Pharsight, Simcyp, Tripos, Synchrogenix, and ClinGenuity —to create an integrated solution to quantitatively inform drug development.

At what dose is a drug safe, efficacious and medically differentiated? In what patient population? With what concomitant medications? We employ the largest team of PhD’s in the industry who are applying math to medicine to answer the most challenging drug development questions, with certainty and predictability.

Sounds great, but does it work? In the past three years, we have directly supported 50 new drug approvals, labels and submissions. Global regulators are now making key regulatory decisions, sometimes solely, based on the outcomes of biosimulation. Working with 1,500 companies, 6,000 scientists and leading regulatory agencies, we have substantially reduced the risk, time and cost required to get a drug to market.


  • Make data-driven decisions at all stages of drug development through a quantitative framework
  • Accelerate regulatory approval through integrated strategy, analytics and regulatory writing
  • Leverage all available data on the drug in development, as well as public data on competitors, to achieve the target product profile.
  • Design safer, targeted and more efficient trials
  • Select the right dose for the right patients, the first time
  • Simulate virtual patients in hard to recruit or test patient populations, such as pediatric, elderly and/or organ impaired



About Phoenix WinNonlin

Used by more than 5,000 researchers and 2,000 institutions world-wide, including multiple global regulatory agencies, Phoenix® WinNonlin® is a complete solution with data management, statistical, modeling and graphics tools. With it, researchers can perform:



Saves time spent learning software
Phoenix WinNonlin has an intuitive graphical user interface that is easy to learn. Certara supports its users by offering classroom and onsitetraining courses.
Avoids risk
Microsoft® Excel® is prone to user-generated errors. When data has been changed in Phoenix WinNonlin, it alerts the user who can re-execute the entire analysis with a single click.
Empowers researchers
With Phoenix WinNonlin, researchers can spend more time doing science and less time doing manual data manipulation. Visualize data analysis pathways withgraphical workflows. Create reusable templates from workflows to save up to 75% of time spent on routine analysis.
Meets compliance mandates
The Bioequivalence Wizard in Phoenix WinNonlin 6.4 supports meeting regulatory guidelines for demonstrating bioequivalence. When used with the Phoenix® Knowledgebase Server™, Phoenix WinNonlin users can meet the technical controls for 21 CFR Part 11 compliance.
Facilitates collaboration
The entire project (analysis, documentation, tables, listings, and figures) is stored in a single file that can be easily shared either internally or with external partners.
Supports Validation Environments
validation suite (sold separately) for Phoenix WinNonlin automates onsite validation to save weeks or months of time.




Join me on Linkedin

View Anthony Melvin Crasto Ph.D's profile on LinkedIn

Join me on Facebook FACEBOOK

Join me on twitterFollow amcrasto on Twitter
Join me on google plus Googleplus

09b37-misc2b027LIONEL MY SON

He was only in first standard in school when I was hit by a deadly one in a million spine stroke called acute transverse mylitis, it made me 90% paralysed and bound to a wheel chair, Now I keep him as my source of inspiration and helping millions, thanks to millions of my readers who keep me going and help me to keep my son happy




Sorry, the comment form is closed at this time.


Get every new post on this blog delivered to your Inbox.

Join other followers: